Probiodrug AG to publish its 2014 Annual Report on March 31, 2015

Probiodrug announces enrolment of first patient in Phase 2 Study of novel Treatment for Alzheimer’s disease
Probiodrug to present data on its Anti-pGlu-3 Abeta monoclonal Antibody at the 12th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PDTM 2015), Nice